SCHEMBL7459127

SCHEMBL7459127

Cc1ccc(S(=O)(=O)CCCC2CCCCC2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.61
CYP3A4 P08684 2/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
TSHR P16473 1/20 0.46
TP53 P04637 2/20 0.44
MAPK1 P28482 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 1/20 0.42
HSD17B10 Q99714 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 1/20 0.41
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
MCHR1 Q99705 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6825855 0.89 ALDH1A1 (0.56) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL8171108 0.85 ALDH1A1 (0.57) ALDH1A1CYP3A4CYP2C9CYP2C19MAPK1
SCHEMBL7787695 0.84 KMT2A (0.52) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL10228581 0.82 ALDH1A1 (0.53) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL6825585 0.80 CRBN (0.53) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL27143232 0.79 ALDH1A1 (0.50) ALDH1A1CYP3A4CYP2C9CYP2C19MAPK1
SCHEMBL3387501 0.79 ALDH1A1 (0.44) ALDH1A1CYP3A4TSHRTP53KMT2A
Butylcyclohexane SCHEMBL31082847 0.78 CYP1A2 (0.51) ALDH1A1CYP3A4TSHRKMT2AMEN1
SCHEMBL7321913 0.78 ALDH1A1 (0.43) ALDH1A1CYP3A4TSHRTP53KMT2A
SCHEMBL7028589 0.78 CYP3A4 (0.43) ALDH1A1CYP3A4TSHRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448282-B1 H3 HISTAMINE RECEPTOR ANTAGONIST ACTIVITY; ALLERGY, INFLAMMATION, CARDIOVASCULAR DISEASE, DEPRESSION, SCHIZOPHRENIA, NARCOLEPSY, SLEEP APNEA, INSOMNIA, EPILEPSY, HYPOTHALAMIC DYSFUNCTION GLIATECH, INC. 2002-09-10 US disclosed
EP-0841922-B1 1H-4(5)-SUBSTITUTED IMIDAZOLE DERIVATIVES GLIATECH INC (US) 2002-02-20 EP disclosed
US-6166060-A 1H-4(5)-substituted imidazole derivatives GLIATECH, INC. (US) 2000-12-26 US disclosed
EP-0841922-A4 1H-4(5)-SUBSTITUTED IMIDAZOLE DERIVATIVES GLIATECH INC (US) 1999-03-10 EP disclosed
EP-0841922-A1 1H-4(5)-SUBSTITUTED IMIDAZOLE DERIVATIVES GLIATECH, INC. (US) 1998-05-20 EP disclosed
WO-1996038142-A1 1H-4(5)-SUBSTITUTED IMIDAZOLE DERIVATIVES GLIATECH, INC. (US) 1996-12-05 WO disclosed